A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma
Clinical trial NCT03234595 · COMPLETED
Trial details
- NCT number
- NCT03234595
- Sponsor
- Everfront Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2023-04-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.